{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:53:56Z","timestamp":1793642036276,"version":"4.5.1"},"reference-count":525,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770461"],"award-info":[{"award-number":["81770461"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010083","name":"Hunan Provincial Innovation Foundation for Postgraduate","doi-asserted-by":"publisher","award":["CX2018B532"],"award-info":[{"award-number":["CX2018B532"]}],"id":[{"id":"10.13039\/501100010083","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Lipid Research"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.plipres.2018.12.002","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T11:55:12Z","timestamp":1543924512000},"page":"65-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":197,"special_numbering":"C","title":["Cholesterol transport system: An integrated cholesterol transport model involved in atherosclerosis"],"prefix":"10.1016","volume":"73","author":[{"given":"Xiao-Hua","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Long","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ke","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plipres.2018.12.002_bb0005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","article-title":"Executive summary: heart disease and stroke statistics--2016 update: a report from the American Heart Association","volume":"133","author":"Writing Group M","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2018.12.002_bb0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FJC.0b013e31816a5be3","article-title":"The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-\/- mice","volume":"51","author":"Dai","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/MOL.0b013e3283613a94","article-title":"Cholesterol and atherosclerosis: modulation by oestrogen","volume":"24","author":"Barton","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0020","first-page":"275","article-title":"Dyslipidemia","volume":"71","author":"Kihara","year":"2013","journal-title":"Nihon Rinsho"},{"key":"10.1016\/j.plipres.2018.12.002_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-024911-4.50008-8","article-title":"The metabolic role of lecithin: cholesterol acyltransferase: perspectives form pathology","volume":"11","author":"Glomset","year":"1973","journal-title":"Adv Lipid Res"},{"issue":"Suppl","key":"10.1016\/j.plipres.2018.12.002_bb0030","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1194\/jlr.R800088-JLR200","article-title":"The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis","volume":"50","author":"Rader","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0035","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1194\/jlr.M900024-JLR200","article-title":"ABCA1 plays no role in the centripetal movement of cholesterol from peripheral tissues to the liver and intestine in the mouse","volume":"50","author":"Xie","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/CIRCULATIONAHA.108.825109","article-title":"Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo","volume":"120","author":"Tanigawa","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2018.12.002_bb0045","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1053\/jhep.2000.19811","article-title":"Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI","volume":"32","author":"Jolley","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2018.12.002_bb0050","first-page":"964","article-title":"Niemann-Pick C1-Like 1 and cholesterol uptake","volume":"2012","author":"Wang","year":"1821","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2018.12.002_bb0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cca.2013.06.006","article-title":"Foam cells in atherosclerosis","volume":"424","author":"Yu","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.plipres.2018.12.002_bb0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MOL.0000000000000411","article-title":"News on the molecular regulation and function of hepatic low-density lipoprotein receptor and LDLR-related protein 1","volume":"28","author":"van de Sluis","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0065","first-page":"566","article-title":"HDL functionality in reverse cholesterol transport--challenges in translating data emerging from mouse models to human disease","volume":"2016","author":"Lee-Rueckert","year":"1861","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2018.12.002_bb0070","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7555\/JBR.29.20150067","article-title":"Hypercholesterolemia, low density lipoprotein receptor and proprotein convertase subtilisin\/kexin-type 9","volume":"29","author":"Gu","year":"2015","journal-title":"J Biomed Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0075","first-page":"675","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) in lipid metabolism, atherosclerosis and ischemic stroke","volume":"126","author":"Zhang","year":"2016","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.plipres.2018.12.002_bb0080","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.117.030950","article-title":"Benefit of adding ezetimibe to statin therapy on cardiovascular outcomes and safety in patients with vs. Without diabetes: results from IMPROVE-IT","volume":"137","author":"Giugliano","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2018.12.002_bb0085","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further cardiovascular outcomes research With pCSK9 inhibition in subjects with elevated risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2018.12.002_bb0090","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1194\/jlr.M800669-JLR200","article-title":"Membrane topology of human NPC1L1, a key protein in enterohepatic cholesterol absorption","volume":"50","author":"Wang","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MOL.0b013e3282f9b563","article-title":"The structure and function of Niemann-Pick C1-like 1 protein","volume":"19","author":"Yu","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0100","doi-asserted-by":"crossref","first-page":"6616","DOI":"10.1074\/jbc.M511123200","article-title":"Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake","volume":"281","author":"Yu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0105","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1074\/jbc.M707944200","article-title":"Purified NPC1 protein: II. Localization of sterol binding to a 240-amino acid soluble luminal loop","volume":"283","author":"Infante","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0110","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.cmet.2008.04.001","article-title":"The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1","volume":"7","author":"Ge","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.plipres.2018.12.002_bb0115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm.3417","article-title":"The clathrin adaptor Numb regulates intestinal cholesterol absorption through dynamic interaction with NPC1L1","volume":"20","author":"Li","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb0120","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1034\/j.1600-0854.2002.31202.x","article-title":"Myosin-V, a versatile motor for short-range vesicle transport","volume":"3","author":"Langford","year":"2002","journal-title":"Traffic"},{"key":"10.1016\/j.plipres.2018.12.002_bb0125","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1074\/jbc.M511725200","article-title":"Involvement of myosin Vb in glutamate receptor trafficking","volume":"281","author":"Lise","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0130","doi-asserted-by":"crossref","first-page":"22481","DOI":"10.1074\/jbc.M109.034355","article-title":"Requirement of myosin Vb.Rab11a.Rab11-FIP2 complex in cholesterol-regulated translocation of NPC1L1 to the cell surface","volume":"284","author":"Chu","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0135","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1126\/science.aao6575","article-title":"A LIMA1 variant promotes low plasma LDL cholesterol and decreases intestinal cholesterol absorption","volume":"360","author":"Zhang","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.plipres.2018.12.002_bb0140","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.atherosclerosis.2014.09.036","article-title":"Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels","volume":"237","author":"Xie","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0145","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.ATV.0000257627.40486.46","article-title":"Deficiency of Niemann-Pick C1 Like 1 prevents atherosclerosis in ApoE-\/- mice","volume":"27","author":"Davis","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0150","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1126\/science.1093131","article-title":"Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption","volume":"303","author":"Altmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.plipres.2018.12.002_bb0155","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bbrc.2016.09.164","article-title":"Identification and characterization of NPC1L1 variants in Uygur and Kazakh with extreme low-density lipoprotein cholesterol","volume":"479","author":"Yuan","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2018.12.002_bb0160","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/eurheartj\/ehv108","article-title":"Genetic variation in the cholesterol transporter NPC1L1, ischaemic vascular disease, and gallstone disease","volume":"36","author":"Lauridsen","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.plipres.2018.12.002_bb0165","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/jcpt.12176","article-title":"Gene polymorphism and frequencies of the NPC1L1 gene (rs2072183, rs217434 and rs217428) in Japanese patients with dyslipidemia","volume":"39","author":"Kashiwabara","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.plipres.2018.12.002_bb0170","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.atherosclerosis.2015.07.011","article-title":"Common single nucleotide polymorphisms at the NPC1L1 gene locus significantly predict cardiovascular risk in coronary patients","volume":"242","author":"Muendlein","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0175","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1128\/AEM.02926-14","article-title":"Lactobacillus acidophilus ATCC 4356 prevents atherosclerosis via inhibition of intestinal cholesterol absorption in apolipoprotein E-knockout mice","volume":"80","author":"Huang","year":"2014","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0180","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1101\/sqb.2002.67.491","article-title":"SREBPs: transcriptional mediators of lipid homeostasis","volume":"67","author":"Horton","year":"2002","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0185","doi-asserted-by":"crossref","first-page":"G369","DOI":"10.1152\/ajpgi.00306.2006","article-title":"Modulation of human Niemann-Pick C1-like 1 gene expression by sterol: role of sterol regulatory element binding protein 2","volume":"292","author":"Alrefai","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0190","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1194\/jlr.M900274-JLR200","article-title":"HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liver","volume":"51","author":"Pramfalk","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12944-016-0395-0","article-title":"Bisphenol A promotes cholesterol absorption in Caco-2 cells by up-regulation of NPC1L1 expression","volume":"16","author":"Feng","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0200","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s11095-007-9496-9","article-title":"HNF4alpha is a crucial modulator of the cholesterol-dependent regulation of NPC1L1","volume":"25","author":"Iwayanagi","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0205","doi-asserted-by":"crossref","first-page":"513","DOI":"10.5483\/BMBRep.2015.48.9.253","article-title":"Transcriptional regulation of Niemann-Pick C1-like 1 gene by liver receptor homolog-1","volume":"48","author":"Lee","year":"2015","journal-title":"BMB Rep"},{"key":"10.1016\/j.plipres.2018.12.002_bb0210","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/hep.22439","article-title":"Hepatocyte nuclear factor 4alpha is implicated in endoplasmic reticulum stress-induced acute phase response by regulating expression of cyclic adenosine monophosphate responsive element binding protein H","volume":"48","author":"Luebke-Wheeler","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2018.12.002_bb0215","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.molmet.2016.09.004","article-title":"Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing Npc1l1 expression","volume":"5","author":"Kikuchi","year":"2016","journal-title":"Mol Metab"},{"key":"10.1016\/j.plipres.2018.12.002_bb0220","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00109-017-1575-8","article-title":"Mechanisms of foam cell formation in atherosclerosis","volume":"95","author":"Chistiakov","year":"2017","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.plipres.2018.12.002_bb0225","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0230","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/ATVBAHA.108.169144","article-title":"Macrophage function and its impact on atherosclerotic lesion composition, progression, and stability: the good, the bad, and the ugly","volume":"28","author":"Dickhout","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0235","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4137\/BBI.S12276","article-title":"Three dimensional structure prediction of fatty acid binding site on human transmembrane receptor CD36","volume":"7","author":"Tarhda","year":"2013","journal-title":"Bioinform Biol Insights"},{"key":"10.1016\/j.plipres.2018.12.002_bb0240","doi-asserted-by":"crossref","first-page":"34875","DOI":"10.1074\/jbc.273.52.34875","article-title":"Recombinant glutathione S-transferase\/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain","volume":"273","author":"Pearce","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0245","doi-asserted-by":"crossref","first-page":"45931","DOI":"10.1074\/jbc.M307722200","article-title":"Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1","volume":"278","author":"Zeng","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0250","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1161\/01.ATV.0000220171.50282.0c","article-title":"The di-leucine motif contributes to class a scavenger receptor-mediated internalization of acetylated lipoproteins","volume":"26","author":"Chen","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0255","doi-asserted-by":"crossref","first-page":"49982","DOI":"10.1074\/jbc.M209649200","article-title":"Scavenger receptors class A-I\/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages","volume":"277","author":"Kunjathoor","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0260","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/1440-1681.12302","article-title":"Circulating CD36 and fractalkine levels are associated with vulnerable plaque progression in patients with unstable angina pectoris","volume":"41","author":"Li","year":"2014","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0265","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.atherosclerosis.2007.09.006","article-title":"Class A macrophage scavenger receptor gene expression levels in peripheral blood mononuclear cells specifically increase in patients with acute coronary syndrome","volume":"198","author":"Nakayama","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0270","doi-asserted-by":"crossref","first-page":"20154","DOI":"10.1038\/srep20154","article-title":"Lanatoside C promotes foam cell formation and atherosclerosis","volume":"6","author":"Shi","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.plipres.2018.12.002_bb0275","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12192-013-0417-z","article-title":"Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36","volume":"18","author":"Zhou","year":"2013","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.plipres.2018.12.002_bb0280","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1258\/ebm.2010.010308","article-title":"Hydrogen sulfide inhibits macrophage-derived foam cell formation","volume":"236","author":"Zhao","year":"2011","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.plipres.2018.12.002_bb0285","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cvr\/cvq235","article-title":"Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors","volume":"88","author":"Makinen","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0290","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1172\/JCI24061","article-title":"Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice","volume":"115","author":"Moore","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2018.12.002_bb0295","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.113.005015","article-title":"Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis","volume":"129","author":"Allahverdian","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2018.12.002_bb0300","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1476-511X-10-53","article-title":"Oleic acid induces smooth muscle foam cell formation and enhances atherosclerotic lesion development via CD36","volume":"10","author":"Ma","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0305","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bbrc.2015.01.010","article-title":"Nifedipine inhibits ox-LDL-induced lipid accumulation in human blood-derived macrophages","volume":"457","author":"Zhang","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2018.12.002_bb0310","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1021\/acs.jafc.6b05832","article-title":"Epigallocatechin-3-gallate reduces scavenger receptor A expression and foam cell formation in human macrophages","volume":"65","author":"Chen","year":"2017","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0315","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/34432","article-title":"A serine\/threonine kinase gene defective in Peutz-Jeghers syndrome","volume":"391","author":"Hemminki","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2018.12.002_bb0320","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ng0198-38","article-title":"Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase","volume":"18","author":"Jenne","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.plipres.2018.12.002_bb0325","doi-asserted-by":"crossref","first-page":"35839","DOI":"10.1074\/jbc.M109.057273","article-title":"Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction","volume":"284","author":"Ikeda","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0330","doi-asserted-by":"crossref","first-page":"22291","DOI":"10.1074\/jbc.M110.123794","article-title":"LKB1 deficiency in Tie2-Cre-expressing cells impairs ischemia-induced angiogenesis","volume":"285","author":"Ohashi","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0335","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1126\/science.1120781","article-title":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin","volume":"310","author":"Shaw","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.plipres.2018.12.002_bb0340","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCRESAHA.117.311546","article-title":"Macrophage liver kinase B1 inhibits foam cell formation and atherosclerosis","volume":"121","author":"Liu","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0345","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tox.2017.02.006","article-title":"Varenicline enhances oxidized LDL uptake by increasing expression of LOX-1 and CD36 scavenger receptors through alpha7 nAChR in macrophages","volume":"380","author":"Kanaoka","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.plipres.2018.12.002_bb0350","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.prostaglandins.2006.06.006","article-title":"PPARgamma activation induces CD36 expression and stimulates foam cell like changes in rVSMCs","volume":"80","author":"Lim","year":"2006","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.plipres.2018.12.002_bb0355","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.atherosclerosis.2016.10.009","article-title":"Endophilin-A2-mediated increase in scavenger receptor expression contributes to macrophage-derived foam cell formation","volume":"254","author":"Huang","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0360","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/CIRCRESAHA.107.168070","article-title":"Deficiency of adipose differentiation-related protein impairs foam cell formation and protects against atherosclerosis","volume":"102","author":"Paul","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0365","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biochi.2016.09.012","article-title":"miR-467b regulates the cholesterol ester formation via targeting ACAT1 gene in RAW 264.7 macrophages","volume":"132","author":"Wang","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.plipres.2018.12.002_bb0370","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1074\/jbc.M116.713818","article-title":"Myeloid Acyl-CoA:cholesterol acyltransferase 1 deficiency reduces lesion macrophage content and suppresses atherosclerosis progression","volume":"291","author":"Huang","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0375","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/ATVBAHA.110.210971","article-title":"Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice","volume":"31","author":"Higashimori","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0380","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/jama.301.11.1131","article-title":"ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial","volume":"301","author":"Meuwese","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.plipres.2018.12.002_bb0385","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1161\/01.CIR.0000147777.12010.EF","article-title":"Effects of the acyl coenzyme A: cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions","volume":"110","author":"Tardif","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2018.12.002_bb0390","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMoa054699","article-title":"Effect of ACAT inhibition on the progression of coronary atherosclerosis","volume":"354","author":"Nissen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb0395","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1074\/jbc.270.11.5772","article-title":"Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol","volume":"270","author":"Warner","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0400","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/ATVBAHA.111.240705","article-title":"Regulation of lipid droplet cholesterol efflux from macrophage foam cells","volume":"32","author":"Ouimet","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0405","doi-asserted-by":"crossref","first-page":"C405","DOI":"10.1152\/ajpcell.00306.2006","article-title":"Stable overexpression of human macrophage cholesteryl ester hydrolase results in enhanced free cholesterol efflux from human THP1 macrophages","volume":"292","author":"Zhao","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0410","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1172\/JCI30485","article-title":"Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr mice","volume":"117","author":"Zhao","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2018.12.002_bb0415","first-page":"643","article-title":"Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte\/macrophages","volume":"2008","author":"Crow","year":"1781","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2018.12.002_bb0420","first-page":"76","article-title":"Reduced atherosclerosis in hormone-sensitive lipase transgenic mice overexpressing cholesterol acceptors","volume":"2003","author":"Choy","year":"1634","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2018.12.002_bb0425","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0022-2275(20)32443-3","article-title":"Paradoxical effect on atherosclerosis of hormone-sensitive lipase overexpression in macrophages","volume":"40","author":"Escary","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0430","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cmet.2009.08.004","article-title":"Ablation of neutral cholesterol ester hydrolase 1 accelerates atherosclerosis","volume":"10","author":"Sekiya","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.plipres.2018.12.002_bb0435","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1194\/jlr.M004259","article-title":"Cholesteryl ester hydrolase activity is abolished in HSL-\/- macrophages but unchanged in macrophages lacking KIAA1363","volume":"51","author":"Buchebner","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0440","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1194\/jlr.M047787","article-title":"Critical role of neutral cholesteryl ester hydrolase 1 in cholesteryl ester hydrolysis in murine macrophages","volume":"55","author":"Sakai","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0445","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCRESAHA.110.226613","article-title":"The critical role of neutral cholesterol ester hydrolase 1 in cholesterol removal from human macrophages","volume":"107","author":"Igarashi","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0450","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40880-017-0219-2","article-title":"Autophagy and multidrug resistance in cancer","volume":"36","author":"Li","year":"2017","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.plipres.2018.12.002_bb0455","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1194\/jlr.R067520","article-title":"Lipids, lysosomes, and autophagy","volume":"57","author":"Jaishy","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0460","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cmet.2011.03.023","article-title":"Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase","volume":"13","author":"Ouimet","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.plipres.2018.12.002_bb0465","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cmet.2012.02.011","article-title":"Autophagy links inflammasomes to atherosclerotic progression","volume":"15","author":"Razani","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.plipres.2018.12.002_bb0470","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/15548627.2017.1327942","article-title":"Prdx1 (peroxiredoxin 1) deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux","volume":"14","author":"Jeong","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.plipres.2018.12.002_bb0475","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2018.02.042","article-title":"Interferon-stimulated gene 15 promotes cholesterol efflux by activating autophagy via the miR-17-5p\/Beclin-1 pathway in THP-1 macrophage-derived foam cells","volume":"827","author":"Huang","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0480","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1194\/jlr.M065888","article-title":"Ursolic acid enhances macrophage autophagy and attenuates atherogenesis","volume":"57","author":"Leng","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2013.09.001","article-title":"Apelin and its receptor APJ in cardiovascular diseases","volume":"428","author":"Yu","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.plipres.2018.12.002_bb0490","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbrc.2015.09.045","article-title":"Apelin-13 impedes foam cell formation by activating Class III PI3K\/Beclin-1-mediated autophagic pathway","volume":"466","author":"Yao","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2018.12.002_bb0495","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00041433-200410000-00007","article-title":"Lysosomal acid lipase and atherosclerosis","volume":"15","author":"Du","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0500","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.ATV.0000107030.22053.1e","article-title":"Reduction of atherosclerotic plaques by lysosomal acid lipase supplementation","volume":"24","author":"Du","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/2213988501711010001","article-title":"Targeting wolman disease and cholesteryl ester storage disease: disease pathogenesis and therapeutic development","volume":"11","author":"Aguisanda","year":"2017","journal-title":"Curr Chem Genom Transl Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb0510","doi-asserted-by":"crossref","first-page":"30624","DOI":"10.1074\/jbc.M111.274381","article-title":"Lysosomal acid lipase deficiency impairs regulation of ABCA1 gene and formation of high density lipoproteins in cholesteryl ester storage disease","volume":"286","author":"Bowden","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0515","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0168-8278(00)80407-9","article-title":"Subclinical course of cholesteryl ester storage disease in an adult with hypercholesterolemia, accelerated atherosclerosis, and liver cancer","volume":"32","author":"Elleder","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0520","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/01.ATV.0000057572.97137.DD","article-title":"Importance of different pathways of cellular cholesterol efflux","volume":"23","author":"Yancey","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0525","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jcmm.12689","article-title":"Macrophage-mediated cholesterol handling in atherosclerosis","volume":"20","author":"Chistiakov","year":"2016","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb0530","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.cell.2017.05.020","article-title":"Structure of the human lipid exporter ABCA1","volume":"169","author":"Qian","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.plipres.2018.12.002_bb0535","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.mol.0000226116.35555.eb","article-title":"Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages","volume":"17","author":"Jessup","year":"2006","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0540","doi-asserted-by":"crossref","first-page":"33053","DOI":"10.1074\/jbc.M005438200","article-title":"Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1","volume":"275","author":"Wang","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0545","doi-asserted-by":"crossref","first-page":"34508","DOI":"10.1074\/jbc.M006738200","article-title":"ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages","volume":"275","author":"Oram","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0550","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.arcmed.2015.05.012","article-title":"Lipid-free apolipoprotein A-I structure: insights into HDL formation and atherosclerosis development","volume":"46","author":"Mei","year":"2015","journal-title":"Arch Med Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0555","doi-asserted-by":"crossref","first-page":"11358","DOI":"10.1073\/pnas.96.20.11358","article-title":"Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway","volume":"96","author":"Takahashi","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.plipres.2018.12.002_bb0560","doi-asserted-by":"crossref","first-page":"43564","DOI":"10.1074\/jbc.M107938200","article-title":"Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes\/lysosomes","volume":"276","author":"Chen","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0565","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1073\/pnas.092327399","article-title":"Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues","volume":"99","author":"van Eck","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.plipres.2018.12.002_bb0570","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/ATVBAHA.107.146068","article-title":"In vivo reverse cholesterol transport from macrophages lacking ABCA1 expression is impaired","volume":"27","author":"Wang","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0575","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/01.ATV.0000208364.22732.16","article-title":"Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice","volume":"26","author":"Van Eck","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0580","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1172\/JCI0215748","article-title":"Increased ABCA1 activity protects against atherosclerosis","volume":"110","author":"Singaraja","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2018.12.002_bb0585","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1388-1981(00)00157-8","article-title":"Tangier disease and ABCA1","volume":"1529","author":"Oram","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2018.12.002_bb0590","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.jacc.2005.06.066","article-title":"Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City Heart Study Population","volume":"46","author":"Frikke-Schmidt","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0595","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/ATVBAHA.107.153858","article-title":"Genetic variation in ABCA1 predicts ischemic heart disease in the general population","volume":"28","author":"Frikke-Schmidt","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0600","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.299.21.2524","article-title":"Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease","volume":"299","author":"Frikke-Schmidt","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.plipres.2018.12.002_bb0605","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/01.RES.0000237920.70451.ad","article-title":"Specific mutations in ABCA1 have discrete effects on ABCA1 function and lipid phenotypes both in vivo and in vitro","volume":"99","author":"Singaraja","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0610","doi-asserted-by":"crossref","first-page":"28240","DOI":"10.1074\/jbc.M003337200","article-title":"Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor\/retinoid X receptor","volume":"275","author":"Costet","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0615","first-page":"581","article-title":"Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages","volume":"25","author":"Tang","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.plipres.2018.12.002_bb0620","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejphar.2017.05.055","article-title":"Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages","volume":"811","author":"Li","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0625","doi-asserted-by":"crossref","first-page":"493","DOI":"10.5551\/jat.3152","article-title":"TGF-beta1 up-regulates expression of ABCA1, ABCG1 and SR-BI through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells","volume":"17","author":"Hu","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.plipres.2018.12.002_bb0630","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.atherosclerosis.2008.07.029","article-title":"IFN-gamma down-regulates ABCA1 expression by inhibiting LXRalpha in a JAK\/STAT signaling pathway-dependent manner","volume":"203","author":"Hao","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0635","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1093\/eurheartj\/ehx315","article-title":"TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis","volume":"38","author":"Lake","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.plipres.2018.12.002_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2016.11.019","article-title":"Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages","volume":"256","author":"Adorni","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0645","doi-asserted-by":"crossref","first-page":"11172","DOI":"10.1074\/jbc.M116.726729","article-title":"Poly(ADP-ribose) polymerase 1 represses liver X receptor-mediated ABCA1 expression and cholesterol efflux in macrophages","volume":"291","author":"Shrestha","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0650","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s10529-017-2345-y","article-title":"Squalene promotes cholesterol homeostasis in macrophage and hepatocyte cells via activation of liver X receptor (LXR) alpha and beta","volume":"39","author":"Hien","year":"2017","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.plipres.2018.12.002_bb0655","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/cbin.10712","article-title":"CYP19A1, MIF and ABCA1 genes are targets of the RORalpha in monocyte and endothelial cells","volume":"41","author":"Coban","year":"2017","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.plipres.2018.12.002_bb0660","doi-asserted-by":"crossref","first-page":"12427","DOI":"10.1074\/jbc.M100218200","article-title":"The zinc finger protein 202 (ZNF202) is a transcriptional repressor of ATP binding cassette transporter A1 (ABCA1) and ABCG1 gene expression and a modulator of cellular lipid efflux","volume":"276","author":"Porsch-Ozcurumez","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0665","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/abbs\/gmw013","article-title":"Macrophage-activating lipopeptide-2 downregulates the expression of ATP-binding cassette transporter A1 by activating the TLR2\/NF-small ka, CyrillicB\/ZNF202 pathway in THP-1 macrophages","volume":"48","author":"Peng","year":"2016","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.plipres.2018.12.002_bb0670","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1253\/circj.CJ-11-1338","article-title":"Interleukin-18 and interleukin-12 together downregulate ATP-binding cassette transporter A1 expression through the interleukin-18R\/nuclear factor-kappaB signaling pathway in THP-1 macrophage-derived foam cells","volume":"76","author":"Yu","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.plipres.2018.12.002_bb0675","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.atherosclerosis.2010.06.024","article-title":"Transcriptional factor prolactin regulatory element-binding protein-mediated gene transcription of ABCA1 via 3',5'-cyclic adenosine-5'-monophosphate","volume":"212","author":"Nishiuchi","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0680","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1016\/j.febslet.2006.07.001","article-title":"Platelet derived growth factor regulates ABCA1 expression in vascular smooth muscle cells","volume":"580","author":"Nagao","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.plipres.2018.12.002_bb0685","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1055\/s-0035-1569272","article-title":"Insulin-like growth factor 1 regulates the expression of ATP-binding cassette transporter A1 in pancreatic beta cells","volume":"48","author":"Lyu","year":"2016","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0690","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1089\/dna.2012.1940","article-title":"Posttranscriptional regulation of ATP-binding cassette transporter A1 in lipid metabolism","volume":"32","author":"Lv","year":"2013","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0695","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1172\/JCI200316808","article-title":"A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I","volume":"111","author":"Wang","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2018.12.002_bb0700","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1021\/acs.biochem.5b00894","article-title":"LXR agonism upregulates the macrophage ABCA1\/syntrophin protein complex that can bind ApoA-I and stabilized ABCA1 protein, but complex loss does not inhibit lipid efflux","volume":"54","author":"Tamehiro","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.plipres.2018.12.002_bb0705","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1006\/geno.2002.6761","article-title":"Cloning and characterization of a novel apolipoprotein A-I binding protein, AI-BP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I","volume":"79","author":"Ritter","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.plipres.2018.12.002_bb0710","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.atherosclerosis.2016.03.008","article-title":"Apolipoprotein A-1 binding protein promotes macrophage cholesterol efflux by facilitating apolipoprotein A-1 binding to ABCA1 and preventing ABCA1 degradation","volume":"248","author":"Zhang","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0715","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.atherosclerosis.2018.03.010","article-title":"AIBP reduces atherosclerosis by promoting reverse cholesterol transport and ameliorating inflammation in apoE(-\/-) mice","volume":"273","author":"Zhang","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0720","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/ATVBAHA.110.203927","article-title":"Calmodulin interacts with ATP binding cassette transporter A1 to protect from calpain-mediated degradation and upregulates high-density lipoprotein generation","volume":"30","author":"Iwamoto","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0725","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0028-1088332","article-title":"Paeonol attenuates high-fat-diet-induced atherosclerosis in rabbits by anti-inflammatory activity","volume":"75","author":"Li","year":"2009","journal-title":"Planta Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb0730","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3892\/ijo.2014.2757","article-title":"Paeonol suppresses lipid accumulation in macrophages via upregulation of the ATPbinding cassette transporter A1 and downregulation of the cluster of differentiation 36","volume":"46","author":"Li","year":"2015","journal-title":"Int J Oncol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0735","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jnutbio.2010.08.014","article-title":"Wogonin promotes cholesterol efflux by increasing protein phosphatase 2B-dependent dephosphorylation at ATP-binding cassette transporter-A1 in macrophages","volume":"22","author":"Chen","year":"2011","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0740","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.atherosclerosis.2008.11.003","article-title":"Eicosapentaenoic acid reduces ABCA1 serine phosphorylation and impairs ABCA1-dependent cholesterol efflux through cyclic AMP\/protein kinase A signaling pathway in THP-1 macrophage-derived foam cells","volume":"204","author":"Hu","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0745","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/jcb.24478","article-title":"Hyperglycemia accelerates ATP-binding cassette transporter A1 degradation via an ERK-dependent pathway in macrophages","volume":"114","author":"Chang","year":"2013","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0750","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bbrc.2017.03.047","article-title":"Nucleolin protects macrophages from oxLDL-induced foam cell formation through up-regulating ABCA1 expression","volume":"486","author":"Li","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2018.12.002_bb0755","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1074\/jbc.M109.073601","article-title":"Inhibition of ERK1\/2 and activation of liver X receptor synergistically induce macrophage ABCA1 expression and cholesterol efflux","volume":"285","author":"Zhou","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0760","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1194\/jlr.M044925","article-title":"RNA binding protein HuR regulates the expression of ABCA1","volume":"55","author":"Ramirez","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0765","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tcm.2010.03.006","article-title":"Adenosine-triphosphate-binding cassette transporter-1 trafficking and function","volume":"20","author":"Kang","year":"2010","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb0770","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCRESAHA.108.193011","article-title":"Palmitoylation of ATP-binding cassette transporter A1 is essential for its trafficking and function","volume":"105","author":"Singaraja","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0775","doi-asserted-by":"crossref","first-page":"39971","DOI":"10.1074\/jbc.M605095200","article-title":"Cathepsin D, a lysosomal protease, regulates ABCA1-mediated lipid efflux","volume":"281","author":"Haidar","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0780","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3892\/etm.2017.4515","article-title":"miRNAs in vascular integrity","volume":"14","author":"Cao","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb0785","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MOL.0000000000000420","article-title":"MicroRNAs and lipid metabolism","volume":"28","author":"Aryal","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0790","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.beem.2016.11.010","article-title":"MicroRNAs in lipid metabolism and atherosclerosis","volume":"30","author":"Giral","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.plipres.2018.12.002_bb0795","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2012.11.025","article-title":"MicroRNA-33 in atherosclerosis etiology and pathophysiology","volume":"227","author":"Chen","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0800","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1126\/science.1189862","article-title":"MiR-33 contributes to the regulation of cholesterol homeostasis","volume":"328","author":"Rayner","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.plipres.2018.12.002_bb0805","doi-asserted-by":"crossref","first-page":"17321","DOI":"10.1073\/pnas.1008499107","article-title":"MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo","volume":"107","author":"Horie","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.plipres.2018.12.002_bb0810","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI57275","article-title":"Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis","volume":"121","author":"Rayner","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2018.12.002_bb0815","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.atherosclerosis.2014.05.943","article-title":"Chlamydia pneumoniae negatively regulates ABCA1 expression via TLR2-Nuclear factor-kappa B and miR-33 pathways in THP-1 macrophage-derived foam cells","volume":"235","author":"Zhao","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0820","first-page":"929","article-title":"MicroRNA-20a\/b regulates cholesterol efflux through post-transcriptional repression of ATP-binding cassette transporter A1","volume":"2017","author":"Liang","year":"1862","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2018.12.002_bb0825","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1161\/ATVBAHA.111.232066","article-title":"MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1","volume":"31","author":"Ramirez","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0830","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.atherosclerosis.2014.07.005","article-title":"MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1","volume":"236","author":"Lv","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0835","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.atherosclerosis.2014.02.008","article-title":"MicroRNA-27a\/b regulates cellular cholesterol efflux, influx and esterification\/hydrolysis in THP-1 macrophages","volume":"234","author":"Zhang","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0840","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.atherosclerosis.2015.02.044","article-title":"Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1","volume":"240","author":"Lv","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0845","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yexcr.2015.05.023","article-title":"MicroRNA-101 overexpression by IL-6 and TNF-alpha inhibits cholesterol efflux by suppressing ATP-binding cassette transporter A1 expression","volume":"336","author":"Zhang","year":"2015","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0850","first-page":"674","article-title":"Up-regulated miR-93 contributes to coronary atherosclerosis pathogenesis through targeting ABCA1","volume":"8","author":"He","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb0855","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/ATVBAHA.114.304878","article-title":"MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis","volume":"35","author":"Meiler","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0860","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1160\/TH13-11-0905","article-title":"MiR-143\/145 deficiency attenuates the progression of atherosclerosis in Ldlr-\/-mice","volume":"112","author":"Sala","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.plipres.2018.12.002_bb0865","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.301","article-title":"Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRalpha expression and cholesterol homeostasis","volume":"4","author":"Adlakha","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0870","doi-asserted-by":"crossref","first-page":"9774","DOI":"10.1073\/pnas.0403506101","article-title":"ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins","volume":"101","author":"Wang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.plipres.2018.12.002_bb0875","doi-asserted-by":"crossref","first-page":"30150","DOI":"10.1074\/jbc.M505368200","article-title":"ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins","volume":"280","author":"Vaughan","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb0880","doi-asserted-by":"crossref","first-page":"19719","DOI":"10.1073\/pnas.1113021108","article-title":"ATP binding cassette transporter G1 (ABCG1) is an intracellular sterol transporter","volume":"108","author":"Tarling","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.plipres.2018.12.002_bb0885","first-page":"781","article-title":"Cellular localization and trafficking of the human ABCG1 transporter","volume":"3","author":"Neufeld","year":"2014","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.plipres.2018.12.002_bb0890","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3892\/etm.2017.4551","article-title":"Tribbles homolog 1 enhances cholesterol efflux from oxidized low-density lipoprotein-loaded THP-1 macrophages","volume":"14","author":"Fu","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb0895","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s11745-016-4178-1","article-title":"Danshensu promotes cholesterol efflux in RAW264.7 macrophages","volume":"51","author":"Gao","year":"2016","journal-title":"Lipids"},{"key":"10.1016\/j.plipres.2018.12.002_bb0900","doi-asserted-by":"crossref","DOI":"10.3390\/nu8070435","article-title":"9-cis beta-carotene increased cholesterol efflux to HDL in macrophages","volume":"8","author":"Bechor","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.plipres.2018.12.002_bb0905","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/aps.2010.166","article-title":"Ibrolipim increases ABCA1\/G1 expression by the LXRalpha signaling pathway in THP-1 macrophage-derived foam cells","volume":"31","author":"Chen","year":"2010","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.plipres.2018.12.002_bb0910","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1253\/circj.CJ-14-0193","article-title":"Advanced oxidation protein products exacerbates lipid accumulation and atherosclerosis through downregulation of ATP-binding cassette transporter A1 and G1 expression in apolipoprotein E knockout mice","volume":"78","author":"Mo","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.plipres.2018.12.002_bb0915","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.ijcard.2013.11.093","article-title":"NF-kappaB suppresses the expression of ATP-binding cassette transporter A1\/G1 by regulating SREBP-2 and miR-33a in mice","volume":"171","author":"Zhao","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0920","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/ATVBAHA.108.168542","article-title":"Overexpression of human ABCG1 does not affect atherosclerosis in fat-fed ApoE-deficient mice","volume":"28","author":"Burgess","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0925","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1161\/01.ATV.0000237629.29842.4c","article-title":"Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice","volume":"26","author":"Out","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0930","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/01.ATV.0000240051.22944.dc","article-title":"Impaired development of atherosclerosis in hyperlipidemic Ldlr-\/- and ApoE-\/- mice transplanted with Abcg1-\/- bone marrow","volume":"26","author":"Baldan","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0935","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1161\/01.ATV.0000242275.92915.43","article-title":"Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-\/- bone marrow","volume":"26","author":"Ranalletta","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0940","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.atherosclerosis.2011.11.024","article-title":"The effect of ABCG1 deficiency on atherosclerotic lesion development in LDL receptor knockout mice depends on the stage of atherogenesis","volume":"221","author":"Meurs","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0945","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3892\/ijmm.2014.1619","article-title":"17beta-estradiol promotes cholesterol efflux from vascular smooth muscle cells through a liver X receptor alpha-dependent pathway","volume":"33","author":"Wang","year":"2014","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb0950","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2012.06.004","article-title":"Cyanidin-3-O-beta-glucoside induces oxysterol efflux from endothelial cells: role of liver X receptor alpha","volume":"223","author":"Wang","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb0955","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00441-016-2518-3","article-title":"The critical role of ABCG1 and PPARgamma\/LXRalpha signaling in TLR4 mediates inflammatory responses and lipid accumulation in vascular smooth muscle cells","volume":"368","author":"Cao","year":"2017","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0960","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fphys.2016.00185","article-title":"beta-cyclodextrins decrease cholesterol release and ABC-associated transporter expression in smooth muscle cells and aortic endothelial cells","volume":"7","author":"Coisne","year":"2016","journal-title":"Front Physiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0965","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/cvr\/cvp388","article-title":"High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance","volume":"86","author":"Xue","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb0970","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.diabres.2013.04.009","article-title":"ATP-binding cassette transporter G1 protects against endothelial dysfunction induced by high glucose","volume":"101","author":"Xue","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.plipres.2018.12.002_bb0975","doi-asserted-by":"crossref","DOI":"10.4081\/hi.2012.e12","article-title":"Overexpression of ABCG1 protein attenuates arteriosclerosis and endothelial dysfunction in atherosclerotic rabbits","volume":"7","author":"Munch","year":"2012","journal-title":"Heart Int"},{"key":"10.1016\/j.plipres.2018.12.002_bb0980","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2016.06.050","article-title":"Endothelial ATP-binding cassette G1 in mouse endothelium protects against hemodynamic-induced atherosclerosis","volume":"477","author":"Xue","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2018.12.002_bb0985","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/ATVBAHA.110.212985","article-title":"Increased atherosclerosis in mice with vascular ATP-binding cassette transporter G1 deficiency--brief report","volume":"30","author":"Westerterp","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0990","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.ATV.0000200082.58536.e1","article-title":"ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I","volume":"26","author":"Gelissen","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb0995","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1194\/jlr.M600218-JLR200","article-title":"ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL","volume":"47","author":"Vaughan","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1000","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1172\/JCI32057","article-title":"Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo","volume":"117","author":"Wang","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2018.12.002_bb1005","first-page":"3900","article-title":"Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice","volume":"117","author":"Yvan-Charvet","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2018.12.002_bb1010","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/ATVBAHA.115.306670","article-title":"Deficiency of ATP-binding cassette transporters A1 and G1 in endothelial cells accelerates atherosclerosis in mice","volume":"36","author":"Westerterp","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1015","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1194\/jlr.M500080-JLR200","article-title":"The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver","volume":"46","author":"Sabol","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1020","first-page":"1180","article-title":"MEK1\/2 inhibitors activate macrophage ABCG1 expression and reverse cholesterol transport-An anti-atherogenic function of ERK1\/2 inhibition","volume":"2016","author":"Zhang","year":"1861","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2018.12.002_bb1025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.apsb.2016.03.005","article-title":"E17110 promotes reverse cholesterol transport with liver X receptor beta agonist activity in vitro","volume":"6","author":"Li","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.plipres.2018.12.002_bb1030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154302","article-title":"Lactobacillus acidophilus K301 inhibits atherogenesis via induction of 24 (S), 25-epoxycholesterol-mediated ABCA1 and ABCG1 production and cholesterol efflux in macrophages","volume":"11","author":"Hong","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2018.12.002_bb1035","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/bab.1328","article-title":"Alpinetin enhances cholesterol efflux and inhibits lipid accumulation in oxidized low-density lipoprotein-loaded human macrophages","volume":"62","author":"Jiang","year":"2015","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.plipres.2018.12.002_bb1040","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.atherosclerosis.2012.03.005","article-title":"PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRalpha through the IGF-I-mediated signaling pathway","volume":"222","author":"Tang","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1045","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.metabol.2008.03.020","article-title":"Determinants of leukocyte adenosine triphosphate-binding cassette transporter G1 gene expression in type 2 diabetes mellitus","volume":"57","author":"Zhou","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.plipres.2018.12.002_bb1050","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.atherosclerosis.2006.07.023","article-title":"AGE-BSA decreases ABCG1 expression and reduces macrophage cholesterol efflux to HDL","volume":"192","author":"Isoda","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1055","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.2337\/db15-0575","article-title":"RAGE suppresses ABCG1-mediated macrophage cholesterol efflux in diabetes","volume":"64","author":"Daffu","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.plipres.2018.12.002_bb1060","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/1440-1681.12262","article-title":"Emodin enhances cholesterol efflux by activating peroxisome proliferator-activated receptor-gamma in oxidized low density lipoprotein-loaded THP1 macrophages","volume":"41","author":"Fu","year":"2014","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bbrc.2013.10.050","article-title":"Arctigenin promotes cholesterol efflux from THP-1 macrophages through PPAR-gamma\/LXR-alpha signaling pathway","volume":"441","author":"Xu","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2018.12.002_bb1070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2011.07.113","article-title":"Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1\/ABCG1 expressions via PPARgamma\/LXRalpha pathway: findings from in vitro and ex vivo studies","volume":"219","author":"Ozasa","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1075","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1074\/jbc.M113.515890","article-title":"Cellular cholesterol regulates ubiquitination and degradation of the cholesterol export proteins ABCA1 and ABCG1","volume":"289","author":"Hsieh","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb1080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-511X-13-27","article-title":"miR-21 attenuates lipopolysaccharide-induced lipid accumulation and inflammatory response: potential role in cerebrovascular disease","volume":"13","author":"Feng","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1085","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.15252\/emmm.201607492","article-title":"Macrophage deficiency of miR-21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis","volume":"9","author":"Canfran-Duque","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb1090","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1161\/ATVBAHA.113.302879","article-title":"Coenzyme Q10 promotes macrophage cholesterol efflux by regulation of the activator protein-1\/miR-378\/ATP-binding cassette transporter G1-signaling pathway","volume":"34","author":"Wang","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1095","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/mnfr.201500186","article-title":"Coenzyme Q10 consumption promotes ABCG1-mediated macrophage cholesterol efflux: a randomized, double-blind, placebo-controlled, cross-over study in healthy volunteers","volume":"59","author":"Yan","year":"2015","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1100","first-page":"847","article-title":"Caveolin-1 interacts with ATP binding cassette transporter G1 (ABCG1) and regulates ABCG1-mediated cholesterol efflux","volume":"2014","author":"Gu","year":"1841","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2018.12.002_bb1105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00041433-199908000-00007","article-title":"Scavenger receptor BI and cholesterol trafficking","volume":"10","author":"Williams","year":"1999","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1110","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0022-2275(20)31525-X","article-title":"Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL","volume":"42","author":"de La Llera-Moya","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1115","doi-asserted-by":"crossref","first-page":"36596","DOI":"10.1074\/jbc.M006924200","article-title":"High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI","volume":"275","author":"Yancey","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb1120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.atherosclerosis.2011.03.017","article-title":"Scavenger receptor SR-BI in macrophage lipid metabolism","volume":"217","author":"Ji","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1125","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0022-2275(20)32462-7","article-title":"Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface","volume":"40","author":"de la Llera-Moya","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/bi991666c","article-title":"Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution","volume":"39","author":"Kellner-Weibel","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.plipres.2018.12.002_bb1135","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1194\/jlr.M700274-JLR200","article-title":"The roles of different pathways in the release of cholesterol from macrophages","volume":"48","author":"Adorni","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1140","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1194\/jlr.M600136-JLR200","article-title":"Selective uptake of HDL cholesteryl esters and cholesterol efflux from mouse peritoneal macrophages independent of SR-BI","volume":"47","author":"Brundert","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1194\/jlr.M700200-JLR200","article-title":"SR-BI inhibits ABCG1-stimulated net cholesterol efflux from cells to plasma HDL","volume":"49","author":"Yvan-Charvet","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1150","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1021\/bi0269207","article-title":"Expression of scavenger receptor BI facilitates sterol movement between the plasma membrane and the endoplasmic reticulum in macrophages","volume":"42","author":"Huang","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.plipres.2018.12.002_bb1155","first-page":"846","article-title":"Baicalin and geniposide inhibit the development of atherosclerosis by increasing Wnt1 and inhibiting dickkopf-related protein-1 expression","volume":"13","author":"Wang","year":"2016","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1160","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.3892\/etm.2016.3884","article-title":"Baicalin promotes cholesterol efflux by regulating the expression of SR-BI in macrophages","volume":"12","author":"Yu","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb1165","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1172\/JCI26893","article-title":"Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues","volume":"116","author":"Huby","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2018.12.002_bb1170","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/01.RES.85.1.108","article-title":"Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions","volume":"85","author":"Hirano","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1175","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1161\/01.CIR.0000093189.97429.9D","article-title":"Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice","volume":"108","author":"Zhang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2018.12.002_bb1180","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1161\/01.ATV.0000083343.19940.A0","article-title":"Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells","volume":"23","author":"Covey","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1185","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0002-9440(10)63341-X","article-title":"Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development","volume":"165","author":"Van Eck","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1190","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0021-9150(01)00642-6","article-title":"Identification and expression of scavenger receptor SR-BI in endothelial cells and smooth muscle cells of rat aorta in vitro and in vivo","volume":"161","author":"Yeh","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1195","doi-asserted-by":"crossref","first-page":"607120","DOI":"10.1155\/2015\/607120","article-title":"Endothelial expression of scavenger receptor class B, type I protects against development of atherosclerosis in mice","volume":"2015","author":"Vaisman","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.plipres.2018.12.002_bb1200","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1194\/jlr.M700254-JLR200","article-title":"The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential","volume":"49","author":"Zanotti","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1205","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5551\/jat.14.133","article-title":"Telmisartan enhances cholesterol efflux from THP-1 macrophages by activating PPARgamma","volume":"14","author":"Nakaya","year":"2007","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.plipres.2018.12.002_bb1210","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2261-14-80","article-title":"Cholesterol efflux is LXRalpha isoform-dependent in human macrophages","volume":"14","author":"Ma","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.plipres.2018.12.002_bb1215","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1194\/jlr.M300461-JLR200","article-title":"Sterol regulation of scavenger receptor class B type I in macrophages","volume":"45","author":"Yu","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1220","doi-asserted-by":"crossref","first-page":"16567","DOI":"10.1074\/jbc.M011302200","article-title":"Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor B-I","volume":"276","author":"Han","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb1225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2261-5-25","article-title":"Regulation and splicing of scavenger receptor class B type I in human macrophages and atherosclerotic plaques","volume":"5","author":"Svensson","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.plipres.2018.12.002_bb1230","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2010.01.025","article-title":"Paraoxonase 1 (PON1) deficiency in mice is associated with reduced expression of macrophage SR-BI and consequently the loss of HDL cytoprotection against apoptosis","volume":"211","author":"Fuhrman","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1235","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1128\/MCB.01002-12","article-title":"MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells","volume":"32","author":"Hu","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1240","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/JIR.S12983","article-title":"Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis","volume":"4","author":"Getz","year":"2011","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1245","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.ATV.16.2.328","article-title":"Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly","volume":"16","author":"Palgunachari","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1250","doi-asserted-by":"crossref","first-page":"10313","DOI":"10.1021\/bi980042o","article-title":"Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes","volume":"37","author":"Mishra","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.plipres.2018.12.002_bb1255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.atherosclerosis.2015.08.028","article-title":"Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice","volume":"243","author":"Tiniakou","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1260","first-page":"502","article-title":"Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice","volume":"2012","author":"Sorci-Thomas","year":"1821","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2018.12.002_bb1265","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.atherosclerosis.2014.05.935","article-title":"A novel ApoA-I truncation (ApoA-IMytilene) associated with decreased ApoA-I production","volume":"235","author":"Anthanont","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1270","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2016.04.005","article-title":"A loss-of-function variant in OSBPL1A predisposes to low plasma HDL cholesterol levels and impaired cholesterol efflux capacity","volume":"249","author":"Motazacker","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1275","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1096\/fj.201600508R","article-title":"Human macrophage cathepsin B-mediated C-terminal cleavage of apolipoprotein A-I at Ser228 severely impairs antiatherogenic capacity","volume":"30","author":"Dinnes","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.plipres.2018.12.002_bb1280","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1194\/jlr.M008573","article-title":"Inhibition of collar-induced carotid atherosclerosis by recombinant apoA-I cysteine mutants in apoE-deficient mice","volume":"51","author":"Zhang","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1285","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2011.133","article-title":"Expression of apolipoprotein A-I in rabbit carotid endothelium protects against atherosclerosis","volume":"19","author":"Flynn","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.plipres.2018.12.002_bb1290","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/ATVBAHA.116.308258","article-title":"Local vascular gene therapy with apolipoprotein A-I to promote regression of atherosclerosis","volume":"37","author":"Wacker","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1295","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.addr.2016.04.030","article-title":"A high-density lipoprotein-mediated drug delivery system","volume":"106","author":"Mo","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.plipres.2018.12.002_bb1300","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1388-1981(00)00153-0","article-title":"Lecithin cholesterol acyltransferase","volume":"1529","author":"Jonas","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2018.12.002_bb1305","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/01.ATV.0000104029.74961.f5","article-title":"Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I","volume":"24","author":"Rye","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1310","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.atherosclerosis.2016.11.015","article-title":"High density lipoproteins are modulators of protease activity: implications in inflammation, complement activation, and atherothrombosis","volume":"259","author":"Gordon","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1315","first-page":"325","article-title":"High-density lipoproteins: biology, epidemiology, and clinical management","volume":"33","author":"Choi","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1320","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.amjms.2016.06.014","article-title":"High-density lipoprotein and inflammation and its significance to atherosclerosis","volume":"352","author":"Hu","year":"2016","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.plipres.2018.12.002_bb1325","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2013.10.018","article-title":"CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice","volume":"232","author":"Tardy","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1330","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.atherosclerosis.2014.10.012","article-title":"Heat shock protein 65 promotes atherosclerosis through impairing the properties of high density lipoprotein","volume":"237","author":"Sun","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1335","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"issue":"Suppl","key":"10.1016\/j.plipres.2018.12.002_bb1340","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/0021-9150(96)05852-2","article-title":"High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport","volume":"124","author":"Assmann","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1345","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1161\/CIRCULATIONAHA.117.027966","article-title":"LDL-cholesterol lowering for the primary prevention of cardiovascular disease among men with primary elevations of ldl-cholesterol levels of 190 mg\/dL or above: analyses from the WOSCOPS 5-year randomised trial and 20-year observational follow-up","volume":"136","author":"Vallejo-Vaz","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2018.12.002_bb1350","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa064278","article-title":"HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb1355","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2018.12.002_bb1360","doi-asserted-by":"crossref","first-page":"709756","DOI":"10.1155\/2014\/709756","article-title":"Serum lipids, apolipoproteins, and mortality among coronary artery disease patients","volume":"2014","author":"Ding","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.plipres.2018.12.002_bb1365","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Investigators","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb1370","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb1375","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2018.12.002_bb1380","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1161\/ATVBAHA.110.207977","article-title":"Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels","volume":"30","author":"Corsetti","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1385","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/ATVBAHA.117.307025","article-title":"From high-density lipoprotein cholesterol to measurements of function: prospects for the development of tests for high-density lipoprotein functionality in cardiovascular disease","volume":"38","author":"Sacks","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1390","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/01.ATV.0000146325.93749.a8","article-title":"High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study","volume":"24","author":"Asztalos","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1395","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/01.ATV.0000183727.90611.4f","article-title":"Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial","volume":"25","author":"Asztalos","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1400","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb1405","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S2213-8587(15)00126-6","article-title":"Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study","volume":"3","author":"Saleheen","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1410","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb1415","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1194\/jlr.M500187-JLR200","article-title":"Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux","volume":"46","author":"Asztalos","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1420","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1194\/jlr.M075648","article-title":"Influence of HDL particles on cell-cholesterol efflux under various pathological conditions","volume":"58","author":"Asztalos","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1425","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/ATVBAHA.118.311117","article-title":"HDL (high-density lipoprotein) particles, cell-cholesterol efflux, and coronary heart disease risk: the prebeta-1 paradox","volume":"38","author":"Asztalos","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1430","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ahj.2008.09.022","article-title":"Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients","volume":"157","author":"Bloomfield","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.plipres.2018.12.002_bb1435","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1194\/jlr.M016410","article-title":"Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters","volume":"52","author":"Castro-Perez","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1440","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1194\/jlr.M041541","article-title":"In vivo effects of anacetrapib on prebeta HDL: improvement in HDL remodeling without effects on cholesterol absorption","volume":"54","author":"Wang","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1445","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1194\/jlr.M400191-JLR200","article-title":"Scavenger receptor class B type I is solely responsible for the selective uptake of cholesteryl esters from HDL by the liver and the adrenals in mice","volume":"45","author":"Out","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1450","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/01.ATV.0000149381.16166.c6","article-title":"Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein-associated cholesteryl ester by the liver in mice","volume":"25","author":"Brundert","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1455","doi-asserted-by":"crossref","first-page":"26338","DOI":"10.1074\/jbc.273.41.26338","article-title":"The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain","volume":"273","author":"Gu","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb1460","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2017.01.034","article-title":"SR-BI as target in atherosclerosis and cardiovascular disease \u2013 a comprehensive appraisal of the cellular functions of SR-BI in physiology and disease","volume":"258","author":"Hoekstra","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1465","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.1021\/bi500706x","article-title":"SR-BI\/CD36 chimeric receptors define extracellular subdomains of SR-BI critical for cholesterol transport","volume":"53","author":"Kartz","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.plipres.2018.12.002_bb1470","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1021\/acs.biochem.5b00804","article-title":"Tryptophan 415 is critical for the cholesterol transport functions of scavenger receptor BI","volume":"55","author":"Holme","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.plipres.2018.12.002_bb1475","first-page":"310","article-title":"Influence of PDZK1 on lipoprotein metabolism and atherosclerosis","volume":"2008","author":"Kocher","year":"1782","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2018.12.002_bb1480","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.ATV.20.3.721","article-title":"Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse","volume":"20","author":"Kozarsky","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1485","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1258\/ebm.2011.011032","article-title":"Chitosan oligosaccharide decreases very-low-density lipoprotein triglyceride and increases high-density lipoprotein cholesterol in high-fat-diet-fed rats","volume":"236","author":"Wang","year":"2011","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.plipres.2018.12.002_bb1490","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1258\/ebm.2011.011275","article-title":"Chitosan oligosaccharides promote reverse cholesterol transport and expression of scavenger receptor BI and CYP7A1 in mice","volume":"237","author":"Zong","year":"2012","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.plipres.2018.12.002_bb1495","doi-asserted-by":"crossref","first-page":"926","DOI":"10.5551\/jat.22939","article-title":"Chitosan oligosaccharides attenuate atherosclerosis and decrease non-HDL in ApoE-\/- mice","volume":"22","author":"Yu","year":"2015","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.plipres.2018.12.002_bb1500","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1074\/jbc.274.4.2366","article-title":"Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene","volume":"274","author":"Arai","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb1505","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1194\/jlr.M700355-JLR200","article-title":"Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo","volume":"49","author":"Van Eck","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1510","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1194\/jlr.M400361-JLR200","article-title":"Adenovirus-mediated hepatic overexpression of scavenger receptor class B type I accelerates chylomicron metabolism in C57BL\/6J mice","volume":"46","author":"Out","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1515","doi-asserted-by":"crossref","first-page":"164925","DOI":"10.1155\/2011\/164925","article-title":"Upregulation of scavenger receptor BI by hepatic nuclear factor 4alpha through a peroxisome proliferator-activated receptor gamma-dependent mechanism in liver","volume":"2011","author":"Zhang","year":"2011","journal-title":"PPAR Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1520","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0006-291X(02)02760-2","article-title":"Oxysterol-activated LXRalpha\/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes","volume":"299","author":"Malerod","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2018.12.002_bb1525","doi-asserted-by":"crossref","first-page":"33068","DOI":"10.1074\/jbc.272.52.33068","article-title":"Structure and localization of the human gene encoding SR-BI\/CLA-1. Evidence for transcriptional control by steroidogenic factor 1","volume":"272","author":"Cao","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb1530","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/embo-reports\/kvf238","article-title":"Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I","volume":"3","author":"Schoonjans","year":"2002","journal-title":"EMBO Rep"},{"key":"10.1016\/j.plipres.2018.12.002_bb1535","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.plipres.2018.12.002_bb1540","article-title":"Farnesoid X receptor induces murine scavenger receptor Class B type I via intron binding","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2018.12.002_bb1545","first-page":"1066","article-title":"Low-density lipoprotein upregulate SR-BI through Sp1 Ser702 phosphorylation in hepatic cells","volume":"2016","author":"Yang","year":"1861","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2018.12.002_bb1550","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bbrc.2016.09.110","article-title":"The unfolded protein response is a negative regulator of scavenger receptor class B, type I (SR-BI) expression","volume":"479","author":"Eberhart","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2018.12.002_bb1555","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2013.11.070","article-title":"Urokinase-type plasminogen activator (uPA) decreases hepatic SR-BI expression and impairs HDL-mediated reverse cholesterol transport","volume":"233","author":"Chulsky","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1560","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1074\/jbc.M112.437368","article-title":"Regulation of expression and function of scavenger receptor class B, type I (SR-BI) by Na+\/H+ exchanger regulatory factors (NHERFs)","volume":"288","author":"Hu","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb1565","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1128\/MCB.01580-12","article-title":"MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition","volume":"33","author":"Wang","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1570","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1126\/science.174194","article-title":"Receptor-mediated control of cholesterol metabolism","volume":"191","author":"Brown","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.plipres.2018.12.002_bb1575","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1060458","article-title":"Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein","volume":"292","author":"Garcia","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.plipres.2018.12.002_bb1580","doi-asserted-by":"crossref","first-page":"44044","DOI":"10.1074\/jbc.M208539200","article-title":"ARH is a modular adaptor protein that interacts with the LDL receptor, clathrin, and AP-2","volume":"277","author":"He","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb1585","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1242\/jcs.03217","article-title":"The adaptor protein Dab2 sorts LDL receptors into coated pits independently of AP-2 and ARH","volume":"119","author":"Maurer","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1016\/j.plipres.2018.12.002_bb1590","doi-asserted-by":"crossref","first-page":"29024","DOI":"10.1074\/jbc.M304855200","article-title":"Normal sorting but defective endocytosis of the low density lipoprotein receptor in mice with autosomal recessive hypercholesterolemia","volume":"278","author":"Jones","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb1595","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1194\/jlr.M063065","article-title":"Endocytic adaptors Arh and Dab2 control homeostasis of circulatory cholesterol","volume":"57","author":"Tao","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1600","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/MOL.0000000000000292","article-title":"LDL-cholesterol transport to the endoplasmic reticulum: current concepts","volume":"27","author":"Pfisterer","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1605","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/scientificamerican1184-58","article-title":"How LDL receptors influence cholesterol and atherosclerosis","volume":"251","author":"Brown","year":"1984","journal-title":"Sci Am"},{"key":"10.1016\/j.plipres.2018.12.002_bb1610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189316","article-title":"A novel indel variant in LDLR responsible for familial hypercholesterolemia in a Chinese family","volume":"12","author":"Shu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2018.12.002_bb1615","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.atherosclerosis.2017.06.014","article-title":"Analysis of LDLR variants from homozygous FH patients carrying multiple mutations in the LDLR gene","volume":"263","author":"Jiang","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1620","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/eurheartj\/ehw028","article-title":"Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217","volume":"37","author":"Benn","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.plipres.2018.12.002_bb1625","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI116663","article-title":"Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery","volume":"92","author":"Ishibashi","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2018.12.002_bb1630","doi-asserted-by":"crossref","first-page":"E207","DOI":"10.1152\/ajpendo.2002.282.1.E207","article-title":"LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice","volume":"282","author":"Schreyer","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.plipres.2018.12.002_bb1635","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.ATV.19.5.1223","article-title":"Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet","volume":"19","author":"Merat","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1640","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0092-8674(02)00872-3","article-title":"Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER","volume":"110","author":"Yang","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.plipres.2018.12.002_bb1645","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.molcel.2004.06.019","article-title":"Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain","volume":"15","author":"Radhakrishnan","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.plipres.2018.12.002_bb1650","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2005.12.022","article-title":"Protein sensors for membrane sterols","volume":"124","author":"Goldstein","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.plipres.2018.12.002_bb1655","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2018.12.002_bb1660","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12906-016-1165-2","article-title":"Role of hesperetin in LDL-receptor expression in hepatoma HepG2 cells","volume":"16","author":"Bawazeer","year":"2016","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb1665","doi-asserted-by":"crossref","first-page":"31120","DOI":"10.3402\/fnr.v60.31120","article-title":"Genistein upregulates LDLR levels via JNK-mediated activation of SREBP-2","volume":"60","author":"Kartawijaya","year":"2016","journal-title":"Food Nutr Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1670","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jnutbio.2015.07.009","article-title":"Alginate oligosaccharide enhances LDL uptake via regulation of LDLR and PCSK9 expression","volume":"26","author":"Yang","year":"2015","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.plipres.2018.12.002_bb1675","doi-asserted-by":"crossref","first-page":"17268","DOI":"10.1074\/jbc.M114.570390","article-title":"Protein phosphatase 2A (PP2A) regulates low density lipoprotein uptake through regulating sterol response element-binding protein-2 (SREBP-2) DNA binding","volume":"289","author":"Rice","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb1680","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.atherosclerosis.2011.11.006","article-title":"Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins","volume":"220","author":"Yashiro","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1685","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI29383","article-title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice","volume":"116","author":"Lagace","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2018.12.002_bb1690","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/ATVBAHA.108.179564","article-title":"The LDL receptor","volume":"29","author":"Goldstein","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1695","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1479-5876-12-103","article-title":"Enhanced circulating PCSK9 concentration by berberine through SREBP-2 pathway in high fat diet-fed rats","volume":"12","author":"Jia","year":"2014","journal-title":"J Transl Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb1700","doi-asserted-by":"crossref","first-page":"20107","DOI":"10.1073\/pnas.1111589108","article-title":"FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors","volume":"108","author":"Calkin","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.plipres.2018.12.002_bb1705","doi-asserted-by":"crossref","first-page":"33499","DOI":"10.1074\/jbc.M110.159772","article-title":"Adenosine monophosphate-activated protein kinase induces cholesterol efflux from macrophage-derived foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice","volume":"285","author":"Li","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb1710","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.atherosclerosis.2012.09.033","article-title":"5-Aminoimidazole-4-carboxamide ribonucleoside stabilizes low density lipoprotein receptor mRNA in hepatocytes via ERK-dependent HuR binding to an AU-rich element","volume":"226","author":"Yashiro","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1715","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.atherosclerosis.2015.10.026","article-title":"microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator","volume":"243","author":"Jiang","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1720","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.atherosclerosis.2015.09.033","article-title":"miR-27b inhibits LDLR and ABCA1 expression but does not influence plasma and hepatic lipid levels in mice","volume":"243","author":"Goedeke","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1725","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.3980","article-title":"Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis","volume":"21","author":"Wagschal","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb1730","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.tips.2015.04.002","article-title":"A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion","volume":"36","author":"Temel","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.plipres.2018.12.002_bb1735","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-90-481-8622-8_12","article-title":"Protein mediators of sterol transport across intestinal brush border membrane","volume":"51","author":"Brown","year":"2010","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.plipres.2018.12.002_bb1740","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2013.11.010","article-title":"ABCG5\/ABCG8 in cholesterol excretion and atherosclerosis","volume":"428","author":"Yu","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.plipres.2018.12.002_bb1745","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/iub.1165","article-title":"ATP-binding cassette transporters and cholesterol translocation","volume":"65","author":"Li","year":"2013","journal-title":"IUBMB Life"},{"key":"10.1016\/j.plipres.2018.12.002_bb1750","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1016\/j.febslet.2007.08.052","article-title":"The sterol transporting heterodimer ABCG5\/ABCG8 requires bile salts to mediate cholesterol efflux","volume":"581","author":"Vrins","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.plipres.2018.12.002_bb1755","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1021\/bi902064g","article-title":"Bile acids stimulate ATP hydrolysis in the purified cholesterol transporter ABCG5\/G8","volume":"49","author":"Johnson","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.plipres.2018.12.002_bb1760","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1194\/jlr.M500115-JLR200","article-title":"ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile","volume":"46","author":"Langheim","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1765","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature17666","article-title":"Crystal structure of the human sterol transporter ABCG5\/ABCG8","volume":"533","author":"Lee","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2018.12.002_bb1770","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1194\/jlr.R017855","article-title":"Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk","volume":"52","author":"Calandra","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1775","first-page":"5936","article-title":"Biliary cholesterol secretion: more than a simple ABC","volume":"16","author":"Dikkers","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1780","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1021\/bi800292v","article-title":"Purification and reconstitution of sterol transfer by native mouse ABCG5 and ABCG8","volume":"47","author":"Wang","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.plipres.2018.12.002_bb1785","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/humu.9047","article-title":"Mutations in the human ATP-binding cassette transporters ABCG5 and ABCG8 in sitosterolemia","volume":"20","author":"Heimerl","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1016\/j.plipres.2018.12.002_bb1790","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/humu.1206","article-title":"Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia","volume":"18","author":"Hubacek","year":"2001","journal-title":"Hum Mutat"},{"key":"10.1016\/j.plipres.2018.12.002_bb1795","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1126\/science.290.5497.1771","article-title":"Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters","volume":"290","author":"Berge","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.plipres.2018.12.002_bb1800","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.atherosclerosis.2008.09.018","article-title":"ABCG8 gene polymorphisms, plasma cholesterol concentrations, and risk of cardiovascular disease in familial hypercholesterolemia","volume":"204","author":"Koeijvoets","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1805","doi-asserted-by":"crossref","first-page":"13011","DOI":"10.1038\/ncomms13011","article-title":"Global and hepatocyte-specific ablation of Bmal1 induces hyperlipidaemia and enhances atherosclerosis","volume":"7","author":"Pan","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.plipres.2018.12.002_bb1810","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1194\/jlr.M400167-JLR200","article-title":"High-level expression of ABCG5 and ABCG8 attenuates diet-induced hypercholesterolemia and atherosclerosis in Ldlr-\/- mice","volume":"45","author":"Wilund","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1815","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.metabol.2014.06.014","article-title":"Liver-specific induction of Abcg5 and Abcg8 stimulates reverse cholesterol transport in response to ezetimibe treatment","volume":"63","author":"Altemus","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.plipres.2018.12.002_bb1820","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1194\/jlr.M700470-JLR200","article-title":"Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5\/G8","volume":"49","author":"Calpe-Berdiel","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1825","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.atherosclerosis.2015.10.010","article-title":"Hepatic ABCG5\/G8 overexpression substantially increases biliary cholesterol secretion but does not impact in vivo macrophage-to-feces RCT","volume":"243","author":"Dikkers","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1830","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/hep.26316","article-title":"Scavenger receptor BI and ABCG5\/G8 differentially impact biliary sterol secretion and reverse cholesterol transport in mice","volume":"58","author":"Dikkers","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2018.12.002_bb1835","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5483\/BMBRep.2013.46.6.246","article-title":"Cooperative transcriptional activation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 genes by nuclear receptors including Liver-X-Receptor","volume":"46","author":"Back","year":"2013","journal-title":"BMB Rep"},{"key":"10.1016\/j.plipres.2018.12.002_bb1840","doi-asserted-by":"crossref","first-page":"19211","DOI":"10.1074\/jbc.M109.014860","article-title":"Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol","volume":"284","author":"van der Veen","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb1845","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nature18628","article-title":"TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis","volume":"535","author":"Hsieh","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2018.12.002_bb1850","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nm1785","article-title":"Hepatic insulin resistance directly promotes formation of cholesterol gallstones","volume":"14","author":"Biddinger","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb1855","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1128\/MCB.01894-06","article-title":"Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8","volume":"27","author":"Sumi","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1860","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000465517","article-title":"Inhibition of ceramide decreased the expression of ATP-binding cassette transporter G5\/8 mRNA in an animal model of cholesterol gallstone","volume":"35","author":"Kim","year":"2017","journal-title":"Dig Dis"},{"key":"10.1016\/j.plipres.2018.12.002_bb1865","doi-asserted-by":"crossref","first-page":"22397","DOI":"10.1074\/jbc.M702236200","article-title":"Defects in the leptin axis reduce abundance of the ABCG5-ABCG8 sterol transporter in liver","volume":"282","author":"Sabeva","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb1870","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.metabol.2015.08.005","article-title":"GRP78 rescues the ABCG5 ABCG8 sterol transporter in db\/db mice","volume":"64","author":"Wang","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.plipres.2018.12.002_bb1875","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MOL.0b013e3283395e45","article-title":"Transintestinal cholesterol efflux","volume":"21","author":"van der Velde","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1880","first-page":"5953","article-title":"From blood to gut: direct secretion of cholesterol via transintestinal cholesterol efflux","volume":"16","author":"Vrins","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1885","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.gastro.2004.10.006","article-title":"Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice","volume":"128","author":"Kruit","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.plipres.2018.12.002_bb1890","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/ATVBAHA.116.308558","article-title":"Transintestinal and biliary cholesterol secretion both contribute to macrophage reverse cholesterol transport in rats-brief report","volume":"37","author":"de Boer","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1895","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cmet.2016.10.001","article-title":"Transintestinal cholesterol transport is active in mice and humans and controls ezetimibe-induced fecal neutral sterol excretion","volume":"24","author":"Jakulj","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.plipres.2018.12.002_bb1900","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cmet.2010.05.011","article-title":"Biliary sterol secretion is not required for macrophage reverse cholesterol transport","volume":"12","author":"Temel","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.plipres.2018.12.002_bb1905","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1194\/jlr.M054544","article-title":"Relative roles of ABCG5\/ABCG8 in liver and intestine","volume":"56","author":"Wang","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1910","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1053\/j.gastro.2016.12.037","article-title":"Intestinal farnesoid X receptor controls transintestinal cholesterol excretion in mice","volume":"152","author":"de Boer","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.plipres.2018.12.002_bb1915","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1194\/jlr.M800579-JLR200","article-title":"Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux","volume":"50","author":"Vrins","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1920","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1160\/TH16-01-0043","article-title":"Deleting myeloid IL-10 receptor signalling attenuates atherosclerosis in LDLR-\/- mice by altering intestinal cholesterol fluxes","volume":"116","author":"Stoger","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.plipres.2018.12.002_bb1925","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.jacc.2013.12.055","article-title":"The ABCG5\/8 cholesterol transporter and myocardial infarction versus gallstone disease","volume":"63","author":"Stender","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1930","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1194\/jlr.M022194","article-title":"Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein","volume":"53","author":"Vrins","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1935","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1161\/ATVBAHA.112.300263","article-title":"Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1","volume":"33","author":"Le May","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1940","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084418","article-title":"Reduction of VLDL secretion decreases cholesterol excretion in niemann-pick C1-like 1 hepatic transgenic mice","volume":"9","author":"Marshall","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2018.12.002_bb1945","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1073\/pnas.80.18.5739","article-title":"Cholesterol synthesis and low density lipoprotein uptake are regulated independently in rat small intestinal epithelium","volume":"80","author":"Stange","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.plipres.2018.12.002_bb1950","doi-asserted-by":"crossref","first-page":"17843","DOI":"10.1021\/bi982404y","article-title":"Identification of a receptor mediating absorption of dietary cholesterol in the intestine","volume":"37","author":"Hauser","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.plipres.2018.12.002_bb1955","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1194\/jlr.M034454","article-title":"Intestinal SR-BI does not impact cholesterol absorption or transintestinal cholesterol efflux in mice","volume":"54","author":"Bura","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb1960","doi-asserted-by":"crossref","first-page":"G203","DOI":"10.1152\/ajpgi.90231.2008","article-title":"Regulation of direct transintestinal cholesterol excretion in mice","volume":"295","author":"van der Velde","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1965","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1096\/fj.04-2714fje","article-title":"Protein transduction of Rab9 in Niemann-Pick C cells reduces cholesterol storage","volume":"19","author":"Narita","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.plipres.2018.12.002_bb1970","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2013.12.005","article-title":"Lysosomal integral membrane protein-2: a new player in lysosome-related pathology","volume":"111","author":"Gonzalez","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.plipres.2018.12.002_bb1975","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1172\/JCI200316200","article-title":"FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes","volume":"111","author":"Honig","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2018.12.002_bb1980","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00592-016-0936-z","article-title":"Retrograde cholesterol transport in the human Caco-2\/TC7 cell line: a model to study trans-intestinal cholesterol excretion in atherogenic and diabetic dyslipidemia","volume":"54","author":"Dugardin","year":"2017","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.plipres.2018.12.002_bb1985","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Collaborators","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2018.12.002_bb1990","article-title":"Effects of different types of statins on lipid profile: a perspective on Asians","volume":"15","author":"Meor Anuar Shuhaili","year":"2017","journal-title":"Int J Endocrinol Metab"},{"key":"10.1016\/j.plipres.2018.12.002_bb1995","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.numecd.2014.05.009","article-title":"Resistance and intolerance to statins","volume":"24","author":"Reiner","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2000","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1042\/CS20160872","article-title":"Statins, PCSK9 inhibitors and cholesterol homeostasis: a view from within the hepatocyte","volume":"131","author":"Sniderman","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.plipres.2018.12.002_bb2005","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1161\/STROKEAHA.113.004229","article-title":"Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients","volume":"45","author":"Sirimarco","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.plipres.2018.12.002_bb2010","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1073\/pnas.0500269102","article-title":"The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)","volume":"102","author":"Garcia-Calvo","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.plipres.2018.12.002_bb2015","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1194\/jlr.M600439-JLR200","article-title":"The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin","volume":"48","author":"Telford","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb2020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2008.05.026","article-title":"Vascular protective effects of ezetimibe in ApoE-deficient mice","volume":"203","author":"Nakagami","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2025","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2967\/jnumed.116.177279","article-title":"Evaluation of antiatherogenic properties of ezetimibe using 3H-labeled low-density-lipoprotein cholesterol and 99mTc-cAbVCAM1-5 SPECT in ApoE-\/- mice fed the paigen diet","volume":"58","author":"Dumas","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb2030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142430","article-title":"Ezetimibe attenuates atherosclerosis associated with lipid reduction and inflammation inhibition","volume":"10","author":"Tie","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2018.12.002_bb2035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.atherosclerosis.2012.02.016","article-title":"Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials","volume":"223","author":"Morrone","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2040","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.amjcard.2004.02.060","article-title":"Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia","volume":"93","author":"Ballantyne","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.carrev.2016.11.010","article-title":"Influence of ezetimibe in addition to high-dose atorvastatin therapy on plaque composition in patients with ST-segment elevation myocardial infarction assessed by serial: Intravascular ultrasound with iMap: the OCTIVUS trial","volume":"18","author":"Hougaard","year":"2017","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb2050","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.atherosclerosis.2016.05.025","article-title":"Lipid profile associated with coronary plaque regression in patients with acute coronary syndrome: subanalysis of PRECISE-IVUS trial","volume":"251","author":"Tsujita","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2055","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1536\/ihj.14-311","article-title":"Effect of combination therapy of ezetimibe and rosuvastatin on regression of coronary atherosclerosis in patients with coronary artery disease","volume":"56","author":"Masuda","year":"2015","journal-title":"Int Heart J"},{"key":"10.1016\/j.plipres.2018.12.002_bb2060","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.4238\/2014.April.3.10","article-title":"Effects of atorvastatin in combination with ezetimibe on carotid atherosclerosis in elderly patients with hypercholesterolemia","volume":"13","author":"Luo","year":"2014","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb2065","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1185\/03007990802365094","article-title":"Long-term (48-week) safety of ezetimibe 10 mg\/day coadministered with simvastatin compared to simvastatin alone in patients with primary hypercholesterolemia","volume":"24","author":"Bays","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.plipres.2018.12.002_bb2070","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia","volume":"358","author":"Kastelein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb2075","first-page":"530","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia","volume":"359","author":"Diamond","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb2080","first-page":"514","article-title":"Efficacy and safety of long-term ezetimibe\/simvastatin treatment in patients with familial hypercholesterolemia","volume":"29","author":"Avellone","year":"2010","journal-title":"Int Angiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/ATVBAHA.113.302781","article-title":"Activation of liver X receptor decreases atherosclerosis in Ldlr(-)\/(-) mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells","volume":"34","author":"Kappus","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm820","article-title":"Reciprocal regulation of inflammation and lipid metabolism by liver X receptors","volume":"9","author":"Joseph","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb2095","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00011-012-0529-4","article-title":"Liver X receptor activation attenuates plaque formation and improves vasomotor function of the aortic artery in atherosclerotic ApoE(-\/-) mice","volume":"61","author":"Chen","year":"2012","journal-title":"Inflamm Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb2100","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1073\/pnas.112059299","article-title":"Synthetic LXR ligand inhibits the development of atherosclerosis in mice","volume":"99","author":"Joseph","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.plipres.2018.12.002_bb2105","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1101\/gad.844900","article-title":"Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta","volume":"14","author":"Repa","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.plipres.2018.12.002_bb2110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adhm.201700313","article-title":"Targeted nanotherapeutics encapsulating liver X receptor agonist GW3965 enhance antiatherogenic effects without adverse effects on hepatic lipid metabolism in Ldlr-\/- mice","volume":"6","author":"Yu","year":"2017","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.plipres.2018.12.002_bb2115","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/ATVBAHA.109.195693","article-title":"Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo","volume":"30","author":"Yasuda","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2120","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/mol.116.105213","article-title":"Identification of a novel liver X receptor agonist that regulates the expression of key cholesterol homeostasis genes with distinct pharmacological characteristics","volume":"91","author":"Li","year":"2017","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2125","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1194\/jlr.M900037-JLR200","article-title":"LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse","volume":"50","author":"Quinet","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb2130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1479-5876-6-59","article-title":"Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells","volume":"6","author":"DiBlasio-Smith","year":"2008","journal-title":"J Transl Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb2135","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/0091270009335768","article-title":"Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants","volume":"49","author":"Katz","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2140","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.1038\/s41598-017-08909-8","article-title":"Selective inhibition mechanism of RVX-208 to the second bromodomain of bromo and extraterminal proteins: insight from microsecond molecular dynamics simulations","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.plipres.2018.12.002_bb2145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083190","article-title":"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist","volume":"8","author":"McLure","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2018.12.002_bb2150","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.dib.2016.07.047","article-title":"Data on gene and protein expression changes induced by apabetalone (RVX-208) in ex vivo treated human whole blood and primary hepatocytes","volume":"8","author":"Wasiak","year":"2016","journal-title":"Data Brief"},{"key":"10.1016\/j.plipres.2018.12.002_bb2155","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.jacc.2010.02.035","article-title":"RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo","volume":"55","author":"Bailey","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2014.06.008","article-title":"A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice","volume":"236","author":"Jahagirdar","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2165","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jacc.2010.11.015","article-title":"Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial","volume":"57","author":"Nicholls","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40256-015-0146-z","article-title":"Effect of the BET protein inhibitor, RVX-208, on progression of coronary atherosclerosis: results of the phase 2b, randomized, double-blind, multicenter, ASSURE trial","volume":"16","author":"Nicholls","year":"2016","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.plipres.2018.12.002_bb2175","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1620\/tjem.220.223","article-title":"D-4F, an apolipoprotein A-I mimetic peptide, promotes cholesterol efflux from macrophages via ATP-binding cassette transporter A1","volume":"220","author":"Xie","year":"2010","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb2180","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.2337\/db10-0844","article-title":"Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes","volume":"59","author":"Morgantini","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.plipres.2018.12.002_bb2185","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/187231210791698438","article-title":"L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice","volume":"4","author":"Imaizumi","year":"2010","journal-title":"Drug Metab Lett"},{"key":"10.1016\/j.plipres.2018.12.002_bb2190","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.atherosclerosis.2015.06.018","article-title":"Apolipoprotein A-I mimetic peptide reverses impaired arterial healing after injury by reducing oxidative stress","volume":"241","author":"Rosenbaum","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2195","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1476-511X-12-180","article-title":"The combination of L-4F and simvastatin stimulate cholesterol efflux and related proteins expressions to reduce atherosclerotic lesions in apoE knockout mice","volume":"12","author":"Ying","year":"2013","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/FJC.0b013e3181edaf69","article-title":"Contribution of D4-F to ABCA1 expression and cholesterol efflux in THP-1 macrophage-derived foam cells","volume":"56","author":"Liu","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2205","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/cts.12487","article-title":"Oral apolipoprotein A-I mimetic D-4F lowers HDL-inflammatory index in high-risk patients: a first-in-human multiple-dose, randomized controlled trial","volume":"10","author":"Dunbar","year":"2017","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.plipres.2018.12.002_bb2210","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1194\/jlr.M200475-JLR200","article-title":"Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway","volume":"44","author":"Remaley","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb2215","doi-asserted-by":"crossref","first-page":"32273","DOI":"10.1074\/jbc.M804461200","article-title":"Asymmetry in the lipid affinity of bihelical amphipathic peptides. A structural determinant for the specificity of ABCA1-dependent cholesterol efflux by peptides","volume":"283","author":"Sethi","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2018.12.002_bb2220","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1124\/jpet.110.167890","article-title":"5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice","volume":"334","author":"Amar","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.plipres.2018.12.002_bb2225","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/ATVBAHA.109.200196","article-title":"The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro","volume":"30","author":"Tabet","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2230","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1194\/jlr.M042051","article-title":"Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid","volume":"54","author":"Navab","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb2235","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1194\/jlr.M033555","article-title":"A novel approach to oral apoA-I mimetic therapy","volume":"54","author":"Chattopadhyay","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb2240","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.atherosclerosis.2011.04.001","article-title":"The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins","volume":"217","author":"Di Bartolo","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2245","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1476-511X-10-224","article-title":"The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit","volume":"10","author":"Di Bartolo","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2250","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.atherosclerosis.2011.05.029","article-title":"Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide\/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits","volume":"218","author":"Iwata","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2255","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2015.05.012","article-title":"Newly developed apolipoprotein A-I mimetic peptide promotes macrophage reverse cholesterol transport in vivo","volume":"192","author":"Shimizu","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2260","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000048","article-title":"FAMP, a novel apoA-I mimetic peptide, suppresses aortic plaque formation through promotion of biological HDL function in ApoE-deficient mice","volume":"2","author":"Uehara","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.plipres.2018.12.002_bb2265","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1194\/jlr.R024513","article-title":"Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?","volume":"53","author":"Kunnen","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb2270","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-2275(20)37433-2","article-title":"The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes","volume":"38","author":"Kuivenhoven","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb2275","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/CIRCULATIONAHA.118.034706","article-title":"Complete and partial LCAT deficiency are differentially associated with atherosclerosis","volume":"138","author":"Oldoni","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2018.12.002_bb2280","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2018.07.025","article-title":"Elevated level of lecithin:cholesterol acyltransferase (LCAT) is associated with reduced coronary atheroma burden","volume":"276","author":"Gebhard","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2285","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.metabol.2018.03.003","article-title":"Loss of LCAT activity in the golden Syrian hamster elicits pro-atherogenic dyslipidemia and enhanced atherosclerosis","volume":"83","author":"Dong","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.plipres.2018.12.002_bb2290","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1194\/jlr.M048629","article-title":"Increased plasma cholesterol esterification by LCAT reduces diet-induced atherosclerosis in SR-BI knockout mice","volume":"56","author":"Thacker","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb2295","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/jpet.110.169540","article-title":"Effect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice","volume":"335","author":"Rousset","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.plipres.2018.12.002_bb2300","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCRESAHA.115.306223","article-title":"Safety and tolerability of ACP-501, a recombinant human lecithin:cholesterol acyltransferase, in a phase 1 single-dose escalation study","volume":"118","author":"Shamburek","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb2305","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jacl.2015.12.007","article-title":"Familial lecithin:cholesterol acyltransferase deficiency: first-in-human treatment with enzyme replacement","volume":"10","author":"Shamburek","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2310","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.103.15.1949","article-title":"Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study","volume":"103","author":"Sirtori","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2018.12.002_bb2315","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.jacc.2006.07.040","article-title":"Bone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic mice","volume":"48","author":"Wang","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2320","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/1074248415610216","article-title":"Comparative effects of diet-induced lipid lowering versus lipid lowering along with Apo A-I milano gene therapy on regression of atherosclerosis","volume":"21","author":"Wang","year":"2016","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.plipres.2018.12.002_bb2325","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jacc.2007.09.071","article-title":"Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis","volume":"51","author":"Ibanez","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2330","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jacc.2007.12.012","article-title":"ApoA-I(Milano)\/phospholipid complex: clinical implications of dose-response studies in rabbit atherosclerosis with intravascular ultrasound and magnetic resonance imaging","volume":"51","author":"Zhao","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2335","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","article-title":"Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial","volume":"290","author":"Nissen","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.plipres.2018.12.002_bb2340","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1194\/jlr.M033779","article-title":"Effect of repeated apoA-IMilano\/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys","volume":"54","author":"Kempen","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb2345","doi-asserted-by":"crossref","first-page":"923903","DOI":"10.1155\/2014\/923903","article-title":"Incubation of MDCO-216 (ApoA-IMilano\/POPC) with human serum potentiates ABCA1-mediated cholesterol efflux capacity, generates new prebeta-1 HDL, and causes an increase in HDL size","volume":"2014","author":"Kempen","year":"2014","journal-title":"J Lipids"},{"key":"10.1016\/j.plipres.2018.12.002_bb2350","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ehjcvp\/pvv041","article-title":"A single infusion of MDCO-216 (ApoA-1 Milano\/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease","volume":"2","author":"Kallend","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.plipres.2018.12.002_bb2355","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10557-017-6746-x","article-title":"MDCO-216 does not induce adverse immunostimulation, in contrast to its predecessor ETC-216","volume":"31","author":"Reijers","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.plipres.2018.12.002_bb2360","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jamacardio.2018.2112","article-title":"Effect of infusion of high-density lipoprotein mimetic containing recombinant apolipoprotein A-I milano on coronary disease in patients with an acute coronary syndrome in the MILANO-PILOT trial: a randomized clinical trial","volume":"3","author":"Nicholls","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2365","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/1074248411426144","article-title":"Reconstituted HDL elicits marked changes in plasma lipids following single-dose injection in C57Bl\/6 mice","volume":"17","author":"Chen","year":"2012","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.plipres.2018.12.002_bb2370","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1161\/CIRCULATIONAHA.109.870709","article-title":"Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux","volume":"120","author":"Calkin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2018.12.002_bb2375","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jama.297.15.jpc70004","article-title":"Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial","volume":"297","author":"Tardif","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.plipres.2018.12.002_bb2380","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/ATVBAHA.113.301981","article-title":"Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux","volume":"33","author":"Diditchenko","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2385","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jcph.194","article-title":"A multiple ascending dose study of CSL112, an infused formulation of ApoA-I","volume":"54","author":"Easton","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2390","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/ATVBAHA.114.303720","article-title":"CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects","volume":"34","author":"Gille","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2395","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002171","article-title":"Infusion of reconstituted high-density lipoprotein, CSL112, in patients with atherosclerosis: safety and pharmacokinetic results from a phase 2a randomized clinical trial","volume":"4","author":"Tricoci","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.plipres.2018.12.002_bb2400","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/CIRCRESAHA.116.308685","article-title":"Enhanced HDL functionality in small HDL species produced upon remodeling of HDL by reconstituted HDL, CSL112: effects on cholesterol efflux, anti-inflammatory and antioxidative activity","volume":"119","author":"Didichenko","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb2405","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/CIRCULATIONAHA.116.025687","article-title":"Safety and tolerability of CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I, after acute myocardial infarction: the AEGIS-I Trial (ApoA-I event reducing in ischemic syndromes I)","volume":"134","author":"Michael Gibson","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2018.12.002_bb2410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137584","article-title":"HDL and CER-001 inverse-dose dependent inhibition of atherosclerotic plaque formation in apoE-\/- mice: evidence of ABCA1 down-regulation","volume":"10","author":"Tardy","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2018.12.002_bb2415","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40261-017-0506-3","article-title":"Development of CER-001: preclinical dose selection through to phase I clinical findings","volume":"37","author":"Keyserling","year":"2017","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.plipres.2018.12.002_bb2420","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2016.05.038","article-title":"HDL mimetic CER-001 targets atherosclerotic plaques in patients","volume":"251","author":"Zheng","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2425","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1194\/jlr.M055665","article-title":"Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA","volume":"56","author":"Kootte","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2018.12.002_bb2430","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ahj.2015.01.008","article-title":"The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: the Modifying Orphan Disease Evaluation (MODE) study","volume":"169","author":"Hovingh","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.plipres.2018.12.002_bb2435","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1093\/eurheartj\/ehu171","article-title":"Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial","volume":"35","author":"Tardif","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.plipres.2018.12.002_bb2440","doi-asserted-by":"crossref","first-page":"252","DOI":"10.21037\/cdt.2017.02.01","article-title":"Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burden","volume":"7","author":"Kataoka","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.plipres.2018.12.002_bb2445","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jamacardio.2018.2121","volume":"3","author":"Nicholls","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2450","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/ATVBAHA.117.309114","article-title":"Deficiency of cholesteryl ester transfer protein protects against atherosclerosis in rabbits","volume":"37","author":"Zhang","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2455","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.atherosclerosis.2014.10.104","article-title":"Elevated CETP activity during acute phase of myocardial infarction is independently associated with endothelial dysfunction and adverse clinical outcome","volume":"237","author":"Carvalho","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2460","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.atherosclerosis.2012.12.024","article-title":"Endogenous CETP activity as a predictor of cardiovascular risk: determination of the optimal range","volume":"227","author":"Villard","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2465","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb2470","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1161\/CIRCULATIONAHA.108.772665","article-title":"Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials","volume":"118","author":"Vergeer","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2018.12.002_bb2475","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/bjp.2008.229","article-title":"Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone","volume":"154","author":"Forrest","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2480","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/eurheartj\/ehr348","article-title":"Torcetrapib impairs endothelial function in hypertension","volume":"33","author":"Simic","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.plipres.2018.12.002_bb2485","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(11)61383-4","article-title":"Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial","volume":"378","author":"Fayad","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2018.12.002_bb2490","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb2495","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.amjcard.2016.10.032","article-title":"Lipid-modifying efficacy and tolerability of anacetrapib added to ongoing statin therapy in patients with hypercholesterolemia or low high-density lipoprotein cholesterol","volume":"119","author":"Ballantyne","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2500","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.atherosclerosis.2016.03.017","article-title":"Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with heterozygous familial hypercholesterolemia","volume":"249","author":"Arai","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2505","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.amjcard.2017.03.255","article-title":"A multiregional, randomized evaluation of the lipid-modifying efficacy and tolerability of anacetrapib added to ongoing statin therapy in patients with hypercholesterolemia or low high-density lipoprotein cholesterol","volume":"120","author":"Ballantyne","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2510","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2017.03.009","article-title":"Lipid-modifying efficacy and tolerability of anacetrapib added to ongoing statin therapy in Japanese patients with dyslipidemia","volume":"261","author":"Teramoto","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2515","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"Group HTRC","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb2520","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb2525","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/labinvest.2017.47","article-title":"Accelerated atherosclerosis development in C57Bl6 mice by overexpressing AAV-mediated PCSK9 and partial carotid ligation","volume":"97","author":"Kumar","year":"2017","journal-title":"Lab Invest"},{"key":"10.1016\/j.plipres.2018.12.002_bb2530","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.111.057406","article-title":"Gene inactivation of proprotein convertase subtilisin\/kexin type 9 reduces atherosclerosis in mice","volume":"125","author":"Denis","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2018.12.002_bb2535","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.atherosclerosis.2016.07.910","article-title":"PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placement","volume":"253","author":"Ferri","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2540","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/dom.13114","article-title":"Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: the ODYSSEY DM-INSULIN randomized trial","volume":"19","author":"Leiter","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.plipres.2018.12.002_bb2545","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jacl.2016.12.004","article-title":"Efficacy and safety of the proprotein convertase subtilisin\/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial hypercholesterolemia","volume":"11","author":"Kastelein","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2550","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jacl.2017.09.003","article-title":"Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia","volume":"11","author":"Hovingh","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2555","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(17)32290-0","article-title":"Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial","volume":"390","author":"Giugliano","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2018.12.002_bb2560","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006910","article-title":"Effect of PCSK9 inhibitors on clinical outcomes in patients with hypercholesterolemia: a meta-analysis of 35 randomized controlled trials","volume":"6","author":"Karatasakis","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.plipres.2018.12.002_bb2565","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa1614062","article-title":"Lipid-reduction variability and antidrug-antibody formation with bococizumab","volume":"376","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2018.12.002_bb2570","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5650\/jos.62.97","article-title":"Bovine lactoferrin reduces visceral fat and liver triglycerides in ICR mice","volume":"62","author":"Morishita","year":"2013","journal-title":"J Oleo Sci"},{"key":"10.1016\/j.plipres.2018.12.002_bb2575","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/09168451.2015.1091713","article-title":"Enteric lactoferrin attenuates the development of high-fat and high-cholesterol diet-induced hypercholesterolemia and atherosclerosis in Microminipigs","volume":"80","author":"Morishita","year":"2016","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.plipres.2018.12.002_bb2580","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1139\/bcb-2016-0052","article-title":"Lactoferrin interacts with bile acids and increases fecal cholesterol excretion in rats","volume":"95","author":"Nakamura","year":"2017","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2585","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.smj.0000208120.73327.db","article-title":"Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review","volume":"99","author":"Insull","year":"2006","journal-title":"South Med J"},{"key":"10.1016\/j.plipres.2018.12.002_bb2590","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.atherosclerosis.2016.07.923","article-title":"Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: impact of a fat-modified diet and a resin","volume":"252","author":"Watts","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2595","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0021-9681(78)90076-0","article-title":"Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality","volume":"31","author":"Dorr","year":"1978","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.plipres.2018.12.002_bb2600","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/phar.1317","article-title":"Lower risk of major cardiovascular events associated with adherence to colesevelam HCI","volume":"33","author":"Ye","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.plipres.2018.12.002_bb2605","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jacl.2016.06.013","article-title":"Mortality reduction in patients treated with long-term intensive lipid therapy: 25-year follow-up of the Familial Atherosclerosis Treatment Study-Observational Study","volume":"10","author":"Zhao","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2610","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40256-013-0037-0","article-title":"Role of colesevelam in combination lipid-lowering therapy","volume":"13","author":"Jones","year":"2013","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.plipres.2018.12.002_bb2615","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0140-6736(80)92044-9","article-title":"Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine","volume":"2","author":"West","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2018.12.002_bb2620","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4330\/wjc.v7.i1.26","article-title":"Relationship between vascular endothelium and periodontal disease in atherosclerotic lesions: review article","volume":"7","author":"Saffi","year":"2015","journal-title":"World J Cardiol"},{"key":"10.1016\/j.plipres.2018.12.002_bb2625","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/ATVBAHA.111.238063","article-title":"The beta-chain of cell surface F(0)F(1) ATPase modulates apoA-I and HDL transcytosis through aortic endothelial cells","volume":"32","author":"Cavelier","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Progress in Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782718300225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782718300225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:42:21Z","timestamp":1759012941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163782718300225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":525,"alternative-id":["S0163782718300225"],"URL":"https:\/\/doi.org\/10.1016\/j.plipres.2018.12.002","relation":{},"ISSN":["0163-7827"],"issn-type":[{"value":"0163-7827","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholesterol transport system: An integrated cholesterol transport model involved in atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Progress in Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plipres.2018.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}